Contact Allergens in Prescription Topical Ophthalmic Medications
Sign Up to like & getrecommendations! Published in 2021 at "Dermatitis"
DOI: 10.1097/der.0000000000000751
Abstract: Background/Objective Both active and inactive ingredients in topical ophthalmic agents may cause allergic contact dermatitis. Here, we examined ingredients in prescription topical ophthalmic medications available in the United States. Methods A comprehensive list of topical… read more here.
Keywords: topical ophthalmic; ophthalmic medications; acds core; inactive ingredients ... See more keywords
Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24-year study from Turkey.
Sign Up to like & getrecommendations! Published in 2023 at "Contact dermatitis"
DOI: 10.1111/cod.14309
Abstract: BACKGROUND Allergic contact dermatitis (ACD) from topical ophthalmic medications (TOMs) poses an additional disease burden to patients who already suffer from eye problems. OBJECTIVES To investigate the epidemiological/clinical profile of patients with periorbital ACD from… read more here.
Keywords: tobramycin; ophthalmic medications; contact dermatitis; allergic contact ... See more keywords
Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27113584
Abstract: Keratoconus (KC) is a serious disease that can affect people of any race or nationality, although the exact etiology and pathogenic mechanism are still unknown. In this study, thirty-two FDA-approved ophthalmic drugs were exposed to… read more here.
Keywords: ophthalmic medications; panel topical; keratoconus; mmp mmp ... See more keywords